ATE209649T1 - Tetrahydroimidazo(2,1-a)isochinolinderivate - Google Patents

Tetrahydroimidazo(2,1-a)isochinolinderivate

Info

Publication number
ATE209649T1
ATE209649T1 AT98202076T AT98202076T ATE209649T1 AT E209649 T1 ATE209649 T1 AT E209649T1 AT 98202076 T AT98202076 T AT 98202076T AT 98202076 T AT98202076 T AT 98202076T AT E209649 T1 ATE209649 T1 AT E209649T1
Authority
AT
Austria
Prior art keywords
tetrahydroimidazo
isochinoline derivatives
isochinoline
derivatives
Prior art date
Application number
AT98202076T
Other languages
English (en)
Inventor
Dirk Leysen
Gerardus Stephanus Franc Ruigt
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE209649T1 publication Critical patent/ATE209649T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98202076T 1997-06-26 1998-06-23 Tetrahydroimidazo(2,1-a)isochinolinderivate ATE209649T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201950 1997-06-26

Publications (1)

Publication Number Publication Date
ATE209649T1 true ATE209649T1 (de) 2001-12-15

Family

ID=8228485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98202076T ATE209649T1 (de) 1997-06-26 1998-06-23 Tetrahydroimidazo(2,1-a)isochinolinderivate

Country Status (26)

Country Link
US (1) US5994366A (de)
EP (1) EP0887349B1 (de)
JP (1) JP4339939B2 (de)
KR (1) KR100540317B1 (de)
CN (1) CN1139589C (de)
AR (1) AR013132A1 (de)
AT (1) ATE209649T1 (de)
AU (1) AU737924B2 (de)
BR (1) BR9802286A (de)
CA (1) CA2241469C (de)
CZ (1) CZ293265B6 (de)
DE (1) DE69802624T2 (de)
DK (1) DK0887349T3 (de)
ES (1) ES2169471T3 (de)
HU (1) HUP9801451A3 (de)
ID (1) ID20494A (de)
IL (1) IL124914A (de)
NO (1) NO311028B1 (de)
NZ (1) NZ330722A (de)
PL (1) PL190281B1 (de)
PT (1) PT887349E (de)
RU (1) RU2204560C2 (de)
SG (1) SG66484A1 (de)
TR (1) TR199801175A1 (de)
TW (1) TW513411B (de)
ZA (1) ZA985559B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004251829B2 (en) * 2003-06-20 2009-12-17 F. Hoffmann-La Roche Ag Hexahydropyridoisoqinolines as DPP-IV inhibitors
MY157827A (en) * 2003-06-27 2016-07-29 3M Innovative Properties Co Sulfonamide substituted imidazoquinolines
PE20060653A1 (es) * 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1
RU2409582C2 (ru) * 2004-08-31 2011-01-20 Глэксо Груп Лимитед Конденсированные трициклические производные для лечения психотических расстройств
RU2310653C1 (ru) * 2006-07-17 2007-11-20 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУВПО "КубГТУ") СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ 2-МЕТИЛ-5-(5-МЕТИЛ-2-ФУРИЛ)-4,10-ДИГИДРО-3H-ПИРИДАЗИНО[1,6-b]ИЗОХИНОЛИН-10-ОНА (ВАРИАНТЫ)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624093A (en) * 1970-03-10 1971-11-30 American Home Prod 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols
US4100165A (en) * 1975-06-17 1978-07-11 Sandoz, Inc. Imidazo [2,1-a]isoquinolines

Also Published As

Publication number Publication date
JPH1171373A (ja) 1999-03-16
AR013132A1 (es) 2000-12-13
PL190281B1 (pl) 2005-11-30
HK1018059A1 (en) 1999-12-10
CA2241469C (en) 2008-08-19
AU7319698A (en) 1999-01-07
SG66484A1 (en) 1999-07-20
DK0887349T3 (da) 2002-03-25
CN1203916A (zh) 1999-01-06
IL124914A (en) 2000-10-31
NO311028B1 (no) 2001-10-01
EP0887349A1 (de) 1998-12-30
IL124914A0 (en) 1999-01-26
HUP9801451A3 (en) 1999-03-29
HUP9801451A2 (hu) 1999-02-01
DE69802624T2 (de) 2002-08-01
RU2204560C2 (ru) 2003-05-20
TW513411B (en) 2002-12-11
CZ204898A3 (cs) 1999-08-11
AU737924B2 (en) 2001-09-06
CN1139589C (zh) 2004-02-25
NO982952L (no) 1998-12-28
KR100540317B1 (ko) 2006-04-17
EP0887349B1 (de) 2001-11-28
JP4339939B2 (ja) 2009-10-07
ES2169471T3 (es) 2002-07-01
NZ330722A (en) 1999-08-30
PL327053A1 (en) 1999-01-04
DE69802624D1 (de) 2002-01-10
ZA985559B (en) 1999-01-20
CA2241469A1 (en) 1998-12-26
US5994366A (en) 1999-11-30
BR9802286A (pt) 2000-02-08
ID20494A (id) 1998-12-31
KR19990007323A (ko) 1999-01-25
TR199801175A1 (xx) 1999-01-18
HU9801451D0 (en) 1998-08-28
NO982952D0 (no) 1998-06-25
CZ293265B6 (cs) 2004-03-17
PT887349E (pt) 2002-04-29

Similar Documents

Publication Publication Date Title
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
DK0891978T3 (da) 5H-Thiazol(3,2-a)pyrimidinderivativer
DE59501320D1 (de) Ketotricyclo(5.2.1.0.)decan-Derivate
DE69831821D1 (de) Hochleitungs-zweischichtigesreibungsmaterial
NL300150I1 (nl) 4"-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
DK1005446T3 (da) N-aroylphenylalaninderivater
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
ID19773A (id) Turunan-turunan 1,3,8-triaza-spiro (4,5) dekan-4-ona tersubtitusi-8
NO983169L (no) Hetrosykel-kondenserte morfinoidderivater (31)
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
DK0966437T3 (da) 5-Aroylnaphthalenderivater
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495L (no) Fenoksymetylpiperidin-derivater
ATE209649T1 (de) Tetrahydroimidazo(2,1-a)isochinolinderivate
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee